Hyperthyroidism is a state in which the thyroid gland synthesises and secretes excessive amounts of thyroid hormone. It differs from the broader term thyrotoxicosis, which describes excessive thyroid-hormone action regardless of whether the thyroid itself is actively overproducing hormone. Graves disease is a major cause of Hyperthyroidism and results from stimulating autoantibodies that activate the thyroid-stimulating hormone receptor. Other causes include toxic multinodular goitre and toxic adenoma, in which nodular thyroid tissue produces hormone independently of normal pituitary regulation.
Some forms of thyroiditis cause thyrotoxicosis through leakage of preformed hormone from damaged thyroid cells rather than increased synthesis, and these conditions are therefore not technically Hyperthyroidism in the strict physiological sense. Excess thyroid hormone increases metabolic activity and alters cardiovascular, neurological, gastrointestinal, muscular and skeletal physiology. Common manifestations include heat intolerance, sweating, palpitations, tremor, anxiety, weight loss despite appetite being maintained or increased, frequent bowel movements and muscle weakness.
Graves disease results from an autoimmune process in which immunoglobulins bind to and stimulate the TSH receptor on thyroid follicular cells. Unlike normal TSH stimulation, this antibody-mediated stimulation is not adequately controlled by pituitary negative feedback, so the thyroid continues synthesising and releasing hormones despite high circulating concentrations. The gland may enlarge diffusely, producing a goitre, and increased vascularity can generate a thyroid bruit.
Graves disease can also produce extrathyroidal manifestations, particularly thyroid eye disease, in which autoimmune processes affect orbital tissues and muscles. Skin changes such as pretibial myxoedema are much less common. Toxic multinodular goitre develops when multiple thyroid nodules acquire autonomous hormone-producing capacity, often after years of nodular thyroid disease. A toxic adenoma is a single autonomous nodule. These mechanisms matter because the likelihood of spontaneous remission, the choice of treatment and the interpretation of radionuclide imaging differ among causes.
Excess thyroid hormone increases oxygen consumption, heat production and metabolic turnover. In the cardiovascular system it increases heart rate, myocardial contractility and cardiac output and can lower systemic vascular resistance. Persistent untreated Hyperthyroidism can therefore contribute to atrial fibrillation, heart failure in susceptible patients and other cardiovascular complications. The nervous system can become hyperadrenergic in appearance, with tremor, anxiety, irritability and increased reflex responsiveness. Gastrointestinal motility increases, producing frequent bowel movements or diarrhoea.
Skeletal muscle protein turnover can become abnormal, producing proximal muscle weakness despite increased metabolic activity. Bone turnover accelerates, and prolonged untreated disease can contribute to reduced bone mineral density and increased fracture risk. Reproductive effects can include menstrual irregularity and reduced fertility. The wide range of manifestations reflects the fact that thyroid hormone acts throughout the body rather than affecting only the thyroid gland itself.
Diagnosis generally involves measuring serum TSH and free thyroid hormones. In primary Hyperthyroidism, TSH is usually suppressed because elevated thyroid hormone reduces pituitary TSH secretion. Free T4 may be elevated, and free T3 may be disproportionately elevated in some patients, a pattern sometimes called T3 toxicosis. Thyroid receptor antibodies can support a diagnosis of Graves disease. Radionuclide uptake and scanning can help distinguish increased hormone synthesis from release of stored hormone.
Graves disease usually produces diffuse increased uptake, while toxic adenoma or toxic multinodular disease produces focal or patchy areas of increased activity with suppression of normal tissue. Thyroiditis generally produces low uptake because the gland is not actively synthesising large quantities of new hormone during the thyrotoxic phase. Ultrasound can assess thyroid structure and vascularity but does not by itself establish the cause of thyrotoxicosis.
Treatment of Hyperthyroidism depends on its cause, severity and clinical context. Antithyroid medicines such as carbimazole or methimazole inhibit thyroid hormone synthesis and are commonly used in Graves disease and as preparatory treatment in some other situations. Propylthiouracil has a more restricted role because of safety considerations but may be used in selected circumstances.
Beta-blockers can reduce adrenergic symptoms such as tremor and palpitations while definitive control of thyroid hormone production is being established, but they do not treat the underlying excess hormone synthesis. Radioactive iodine destroys functioning thyroid tissue and is an established definitive treatment for Graves disease and autonomous thyroid tissue. Thyroidectomy provides another definitive option and can be particularly relevant when there is a large goitre, compressive symptoms, suspicious nodules or circumstances in which radioactive iodine is unsuitable. The choice between approaches depends on the underlying cause, disease characteristics and patient-specific factors.
Thyroid storm is the most severe acute manifestation of uncontrolled thyrotoxicosis and involves marked systemic decompensation, often precipitated by infection, surgery, trauma, abrupt treatment interruption or another major physiological stressor. Features can include high fever, severe tachycardia, cardiovascular instability, gastrointestinal symptoms and altered mental status. It is a medical emergency requiring treatment of the precipitating factor together with measures that reduce thyroid-hormone effects and synthesis.
Hyperthyroidism can also produce periodic paralysis in susceptible individuals, particularly in some populations, through shifts in potassium distribution associated with increased thyroid-hormone activity. Thyroid eye disease in Graves disease may require separate ophthalmological management because orbital inflammation can threaten vision in severe cases. Smoking is associated with greater severity of thyroid eye disease. These complications demonstrate that Hyperthyroidism can have consequences beyond the classic symptoms of weight loss and palpitations.
Hyperthyroidism is not synonymous with having a thyroid nodule or goitre. A person can have a structurally enlarged thyroid while remaining euthyroid, and many nodules do not produce excessive hormone. Conversely, Graves disease can cause Hyperthyroidism without a prominent goitre in every patient. Another important distinction is between Hyperthyroidism and thyrotoxicosis caused by thyroiditis or exogenous thyroid hormone.
In thyroiditis, antithyroid medicines that inhibit new hormone synthesis may provide little benefit during the hormone-release phase because the problem is leakage of hormone already stored within the gland. Excess thyroid hormone taken from outside the body can similarly produce thyrotoxicosis without intrinsic thyroid overproduction. Correctly identifying the mechanism prevents inappropriate treatment. Thyroid testing can also be influenced by medications and assay interference, so unexpected laboratory patterns require context.
The natural history of Hyperthyroidism varies considerably. Graves disease may remit after a course of antithyroid treatment in some patients, but relapse is possible, and long-term management may require definitive treatment. Autonomous nodular disease generally has a lower likelihood of spontaneous remission because the underlying nodules remain capable of hormone production. Thyroiditis-associated thyrotoxicosis is often temporary and may transition through a hypothyroid phase before recovery, although permanent Hypothyroidism can occur in some forms.
Untreated persistent Hyperthyroidism can affect the heart, bones, muscles and nervous system, making diagnosis and appropriate control important even when symptoms appear tolerable. Treatment can itself produce Hypothyroidism, particularly after radioactive iodine or thyroidectomy, and this is often managed with hormone replacement. Hyperthyroidism therefore illustrates the importance of distinguishing hormone excess from its cause and of recognising that definitive treatment may intentionally reduce thyroid function enough to require subsequent replacement.
